| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Affinity selection mass spectrometry speeding drug discovery
|
Prudent, Renaud
|
|
|
28 |
11 |
p.
|
artikel
|
| 2 |
A pleiotropic–epistatic entangelement model of drug response
|
Wang, Yu
|
|
|
28 |
11 |
p.
|
artikel
|
| 3 |
Aprocitentan, a dual endothelin-1 (ET-1) antagonist for treating resistant hypertension: Mechanism of action and therapeutic potential
|
Xu, Jingjing
|
|
|
28 |
11 |
p.
|
artikel
|
| 4 |
Artificial intelligence methods in kinase target profiling: Advances and challenges
|
Gu, Shukai
|
|
|
28 |
11 |
p.
|
artikel
|
| 5 |
Deadly interactions: Synergistic manipulations of concurrent pathogen infections potentially enabling future pandemics
|
Roe, Kevin
|
|
|
28 |
11 |
p.
|
artikel
|
| 6 |
DICTrank: The largest reference list of 1318 human drugs ranked by risk of drug-induced cardiotoxicity using FDA labeling
|
Qu, Yanyan
|
|
|
28 |
11 |
p.
|
artikel
|
| 7 |
Drug and gut microbe relationships: Moving beyond antibiotics
|
Kumbhare, Shreyas V.
|
|
|
28 |
11 |
p.
|
artikel
|
| 8 |
Drug Intelligence Science (DIS®): Pioneering a high-resolution translational platform to enhance the probability of success for drug discovery and development
|
Schweizer, Liang
|
|
|
28 |
11 |
p.
|
artikel
|
| 9 |
Dual-action potential of cationic cryptides against infections and cancers
|
Abd El-Aal, Amr A.A.
|
|
|
28 |
11 |
p.
|
artikel
|
| 10 |
ET-traps: Potential therapeutics for preeclampsia
|
Jain, Arjun
|
|
|
28 |
11 |
p.
|
artikel
|
| 11 |
Fiduciary responsibility
|
Kinch, Michael S.
|
|
|
28 |
11 |
p.
|
artikel
|
| 12 |
Fragmented antibodies in non-small cell lung cancer: A novel nano-engineered delivery system for detection and treatment of cancer
|
Nijhawan, Harsh P.
|
|
|
28 |
11 |
p.
|
artikel
|
| 13 |
Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems
|
Aquino-Jarquin, Guillermo
|
|
|
28 |
11 |
p.
|
artikel
|
| 14 |
Impact of GAMP 5, data integrity and QbD on quality assurance in the pharmaceutical industry: How obvious is it?
|
Pedro, Francisca
|
|
|
28 |
11 |
p.
|
artikel
|
| 15 |
In silico co-crystal design: Assessment of the latest advances
|
Essen, Carolina von
|
|
|
28 |
11 |
p.
|
artikel
|
| 16 |
Is the blockbuster imperative broken?
|
Schuhmacher, Alexander
|
|
|
28 |
11 |
p.
|
artikel
|
| 17 |
Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategy
|
Bhise, Ketki
|
|
|
28 |
11 |
p.
|
artikel
|
| 18 |
Lysosome and related protein degradation technologies
|
Zheng, Hongmei
|
|
|
28 |
11 |
p.
|
artikel
|
| 19 |
Medication adherence and pharmaceutical design strategies for pediatric patients: An overview
|
Mu, Yingying
|
|
|
28 |
11 |
p.
|
artikel
|
| 20 |
Metabolic reprogramming: Unveiling the therapeutic potential of targeted therapies against kidney disease
|
Saxena, Shubhangi
|
|
|
28 |
11 |
p.
|
artikel
|
| 21 |
Microneedle-mediated drug delivery for scar prevention and treatment
|
Mbituyimana, Bricard
|
|
|
28 |
11 |
p.
|
artikel
|
| 22 |
Personalized neoantigen cancer vaccines: An analysis of the clinical and commercial potential of ongoing development programs
|
Perrinjaquet, Maurice
|
|
|
28 |
11 |
p.
|
artikel
|
| 23 |
Rationally designed block copolymer-based nanoarchitectures: An emerging paradigm for effective drug delivery
|
Sharma, Rajeev
|
|
|
28 |
11 |
p.
|
artikel
|
| 24 |
Review of the impact of the FDA’s Fast Track Designation on biotechnology companies’ share prices
|
Williamson, Joab
|
|
|
28 |
11 |
p.
|
artikel
|
| 25 |
RIPTACs: A groundbreaking approach to drug discovery
|
Ma, Zonghui
|
|
|
28 |
11 |
p.
|
artikel
|
| 26 |
Role of exosomes in prostate cancer and male fertility
|
Dey, Dwaipayan
|
|
|
28 |
11 |
p.
|
artikel
|
| 27 |
TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 pathology
|
Helmold, Benjamin R.
|
|
|
28 |
11 |
p.
|
artikel
|
| 28 |
Therapeutic targeting of the complement system in ocular disease
|
Rathi, Sonika
|
|
|
28 |
11 |
p.
|
artikel
|
| 29 |
The role of cGAS-STING signaling in ischemic stroke: From immune response to therapeutic targeting
|
Chauhan, Chandan
|
|
|
28 |
11 |
p.
|
artikel
|
| 30 |
Towards holistic Compound Quality Scores: Extending ligand efficiency indices with compound pharmacokinetic characteristics
|
Tautermann, Christofer S.
|
|
|
28 |
11 |
p.
|
artikel
|
| 31 |
Transforming drug discovery with a high-throughput AI-powered platform: A 5-year experience with Patrimony
|
Blaudin de Thé, François-Xavier
|
|
|
28 |
11 |
p.
|
artikel
|
Tijdschrift beschrijving